GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) » Definitions » Scaled Net Operating Assets

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Scaled Net Operating Assets : 0.06 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sichuan Biokin Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sichuan Biokin Pharmaceutical Co's operating assets for the quarter that ended in Mar. 2024 was ¥1,046 Mil. Sichuan Biokin Pharmaceutical Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥964 Mil. Sichuan Biokin Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2023 was ¥1,425 Mil. Therefore, Sichuan Biokin Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.06.


Sichuan Biokin Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Biokin Pharmaceutical Co Scaled Net Operating Assets Chart

Sichuan Biokin Pharmaceutical Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.34 0.40 0.45 0.22

Sichuan Biokin Pharmaceutical Co Quarterly Data
Dec11 Dec12 Dec13 Dec14 Jun15 Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.28 0.29 0.30 0.06

Competitive Comparison of Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets falls into.



Sichuan Biokin Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1021.136-592.667)/1991.433
=0.22

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1425.099 - 403.963
=1021.136

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1273.226 - 184.937 - 495.622
=592.667

Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(1045.529-963.511)/1425.099
=0.06

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=6871.302 - 5825.773
=1045.529

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1715.721 - 73.322 - 678.888
=963.511

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Biokin Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sichuan Biokin Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Biokin Pharmaceutical Co (SHSE:688506) Business Description

Traded in Other Exchanges
N/A
Address
No. 161, Baili Road, No. 1, Building 1, Cross-strait Science and Technology Industrial Park, Wenjiang District, Sichuan Province, Chengdu, CHN, 611130
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Headlines

No Headlines